New research is being presented at AHA 2014, the annual scientific sessions of the American Heart Association, from November 15 to 19, in Chicago.
Meeting Highlights
Dual Antiplatelet Therapy After Stenting
Heart Ischemia & Stress in Women With CAD
Persistent Asthma Linked With CVD
Screening for CAD in Patients With Diabetes
Can Overtreatment of AF Increase Dementia Risk?
News From AHA 2014
Pregnant women with congenital heart disease may have low complication risks during delivery
Trans Fat Consumption is Linked to Diminished Memory in Working-aged Adults
Early detectable vascular disease linked to erectile dysfunction
Moms’ pre-pregnancy weight impacts risk of dying decades later
Cocaine users experience abnormal blood flow, risk heart disease
AHA Perspective on the Potential Impact of the IMPROVE-IT Data
Cholesterol-lowering drug with different action adds to statin’s reduction of cardiovascular risk
Poison control data show energy drinks and young kids don’t mix
Screening or Treating to Goal Equally Effective
Act Two of PARADIGM-HF Not a Show-Stopper
Secondhand Pot Smoke Impairs Arterial Function in Rats
Aspirin Flops in Primary Prevention for Seniors
IMPROVE-IT Proves Ezetimibe Benefit
Routine Mitral Surgery With CABG?
Telephone CPR Guidance Improves Patient Survival
Endocarditis Cases Rise After Predental Antibiotic Use Falls
BP-Medication Use Improves With Low-Cost Community Initiative
HDL Functionality Inversely Linked With CVD Outcomes
PCSK9 Inhibitor Has Potential in Statin Intolerance
No Advantage for Mechanical vs Manual CPR
Cholesterol Guidelines Still Stirring Debate 1 Year Later
Hypoxia, Hypotension ‘Deadly Combo’ in TBI
AHA Sessions Preview: Highlights Include Long-Awaited Controversial Lipid, Stent Trials
More From AHA 2014
ReSuscitation Science Symposium
Cardiovascular Nursing Symposium
